These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 28830352

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. CD137 costimulatory T cell receptor engagement reverses acute disease in lupus-prone NZB x NZW F1 mice.
    Foell J, Strahotin S, O'Neil SP, McCausland MM, Suwyn C, Haber M, Chander PN, Bapat AS, Yan XJ, Chiorazzi N, Hoffmann MK, Mittler RS.
    J Clin Invest; 2003 May; 111(10):1505-18. PubMed ID: 12750400
    [Abstract] [Full Text] [Related]

  • 24. A benzenediamine derivative fc-99 attenuates lupus-like syndrome in MRL/lpr mice related to suppression of pDC activation.
    Ji J, Fan H, Li F, Li X, Dong G, Gong W, Song Y, Liu F, Hua C, Tan R, Dou H, Hou Y.
    Immunol Lett; 2015 Dec; 168(2):355-65. PubMed ID: 26545567
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Pin1-Targeted Therapy for Systemic Lupus Erythematosus.
    Wei S, Yoshida N, Finn G, Kozono S, Nechama M, Kyttaris VC, Zhen Zhou X, Tsokos GC, Ping Lu K.
    Arthritis Rheumatol; 2016 Oct; 68(10):2503-13. PubMed ID: 27159270
    [Abstract] [Full Text] [Related]

  • 27. Genomic view of IFN-alpha response in pre-autoimmune NZB/W and MRL/lpr mice.
    Lu Q, Shen N, Li XM, Chen SL.
    Genes Immun; 2007 Oct; 8(7):590-603. PubMed ID: 17728792
    [Abstract] [Full Text] [Related]

  • 28. TIGIT signalling pathway negatively regulates CD4+ T-cell responses in systemic lupus erythematosus.
    Mao L, Hou H, Wu S, Zhou Y, Wang J, Yu J, Wu X, Lu Y, Mao L, Bosco MJ, Wang F, Sun Z.
    Immunology; 2017 Jul; 151(3):280-290. PubMed ID: 28108989
    [Abstract] [Full Text] [Related]

  • 29. Activation of the STAT1 signalling pathway in lupus nephritis in MRL/lpr mice.
    Dong J, Wang QX, Zhou CY, Ma XF, Zhang YC.
    Lupus; 2007 Jul; 16(2):101-9. PubMed ID: 17402366
    [Abstract] [Full Text] [Related]

  • 30. Mycophenolate mofetil suppresses autoimmunity and mortality in the female NZB x NZW F1 mouse model of systemic lupus erythematosus.
    McMurray RW, Elbourne KB, Lagoo A, Lal S.
    J Rheumatol; 1998 Dec; 25(12):2364-70. PubMed ID: 9858431
    [Abstract] [Full Text] [Related]

  • 31. The Ox40/Ox40 Ligand Pathway Promotes Pathogenic Th Cell Responses, Plasmablast Accumulation, and Lupus Nephritis in NZB/W F1 Mice.
    Sitrin J, Suto E, Wuster A, Eastham-Anderson J, Kim JM, Austin CD, Lee WP, Behrens TW.
    J Immunol; 2017 Aug 15; 199(4):1238-1249. PubMed ID: 28696253
    [Abstract] [Full Text] [Related]

  • 32. Aberrant GITR expression on different T cell subsets and the regulation by glucocorticoid in systemic lupus erythematosus.
    Sun J, Yu N, Li X, Wang L, Pan Y, Li X, Tao J, Chen Z, Wang G.
    Int J Rheum Dis; 2016 Feb 15; 19(2):199-204. PubMed ID: 25293713
    [Abstract] [Full Text] [Related]

  • 33. CXCR3 promotes the production of IgG1 autoantibodies but is not essential for the development of lupus nephritis in NZB/NZW mice.
    Moser K, Kalies K, Szyska M, Humrich JY, Amann K, Manz RA.
    Arthritis Rheum; 2012 Apr 15; 64(4):1237-46. PubMed ID: 22006377
    [Abstract] [Full Text] [Related]

  • 34. Expression and function of inducible costimulator on peripheral blood T cells in patients with systemic lupus erythematosus.
    Yang JH, Zhang J, Cai Q, Zhao DB, Wang J, Guo PE, Liu L, Han XH, Shen Q.
    Rheumatology (Oxford); 2005 Oct 15; 44(10):1245-54. PubMed ID: 15987711
    [Abstract] [Full Text] [Related]

  • 35. Polyclonal B cell activation arises from different mechanisms in lupus-prone (NZB x NZW)F1 and MRL/MpJ-lpr/lpr mice.
    Merino R, Iwamoto M, Fossati L, Izui S.
    J Immunol; 1993 Dec 01; 151(11):6509-16. PubMed ID: 7902378
    [Abstract] [Full Text] [Related]

  • 36. Development of a Janus Kinase Inhibitor Prodrug for the Treatment of Rheumatoid Arthritis.
    Wei X, Wu J, Zhao G, Galdamez J, Lele SM, Wang X, Liu Y, Soni DM, Purdue PE, Mikuls TR, Goldring SR, Wang D.
    Mol Pharm; 2018 Aug 06; 15(8):3456-3467. PubMed ID: 29966420
    [Abstract] [Full Text] [Related]

  • 37. Jak/STAT signaling is involved in the inflammatory infiltration of the kidneys in MRL/lpr mice.
    Wang S, Yang N, Zhang L, Huang B, Tan H, Liang Y, Li Y, Yu X.
    Lupus; 2010 Sep 06; 19(10):1171-80. PubMed ID: 20501525
    [Abstract] [Full Text] [Related]

  • 38. Identification of Cyclin-Dependent Kinase 1 as a Novel Regulator of Type I Interferon Signaling in Systemic Lupus Erythematosus.
    Wu L, Qin Y, Xia S, Dai M, Han X, Wu Y, Zhang X, Ma J, Wang Y, Tang Y, Liu Z, Zhu W, Jallal B, Yao Y, Qu B, Shen N.
    Arthritis Rheumatol; 2016 May 06; 68(5):1222-32. PubMed ID: 26663909
    [Abstract] [Full Text] [Related]

  • 39. Brief Report: CD4+ T Cells From Patients With Systemic Lupus Erythematosus Respond Poorly to Exogenous Interleukin-2.
    Comte D, Karampetsou MP, Kis-Toth K, Yoshida N, Bradley SJ, Kyttaris VC, Tsokos GC.
    Arthritis Rheumatol; 2017 Apr 06; 69(4):808-813. PubMed ID: 27992687
    [Abstract] [Full Text] [Related]

  • 40. Galectin-1-induced down-regulation of T lymphocyte activation protects (NZB x NZW) F1 mice from lupus-like disease.
    Liu SD, Lee S, La Cava A, Motran CC, Hahn BH, Miceli MC.
    Lupus; 2011 Apr 06; 20(5):473-84. PubMed ID: 21335401
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.